| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Maravai LifeSciences (NASDAQ:MRVI) will release its quarterly earnings report on Monday, 2025-08-11. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Maravai LifeSciences to report an earnings per share (EPS) of $-0.08.
The announcement from Maravai LifeSciences is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
During the last quarter, the company reported an EPS missed by $0.01, leading to a 2.83% drop in the share price on the subsequent day.
Here's a look at Maravai LifeSciences's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.04 | -0.01 | 0 |
| EPS Actual | -0.08 | -0.06 | -0.02 | 0 |
| Price Change % | -3.0% | -6.0% | -35.0% | -7.000000000000001% |
Shares of Maravai LifeSciences were trading at $2.025 as of August 07. Over the last 52-week period, shares are down 75.46%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Maravai LifeSciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MRVI
